• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

放射性肺炎相关危险因素的多元回归分析

Multiple regression analysis of risk factors related to radiation pneumonitis.

作者信息

Shi Ling-Ling, Yang Jiang-Hua, Yao Hong-Fa

机构信息

Department of Radiology, Huzhou Central Hospital, Affiliated Central Hospital of Huzhou University, Huzhou 313000, Zhejiang Province, China.

出版信息

World J Clin Cases. 2023 Feb 16;11(5):1040-1048. doi: 10.12998/wjcc.v11.i5.1040.

DOI:10.12998/wjcc.v11.i5.1040
PMID:36874419
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9979302/
Abstract

BACKGROUND

Radiation pneumonitis (RP) is a severe complication of thoracic radiotherapy that may lead to dyspnea and lung fibrosis, and negatively affects patients' quality of life.

AIM

To carry out multiple regression analysis on the influencing factors of radiation pneumonitis.

METHODS

Records of 234 patients receiving chest radiotherapy in Huzhou Central Hospital (Huzhou, Zhejiang Province, China) from January 2018 to February 2021, and the patients were divided into either a study group or a control group based on the presence of radiation pneumonitis or not. Among them, 93 patients with radiation pneumonitis were included in the study group and 141 without radiation pneumonitis were included in the control group. General characteristics, and radiation and imaging examination data of the two groups were collected and compared. Due to the statistical significance observed, multiple regression analysis was performed on age, tumor type, chemotherapy history, forced vital capacity (FVC), forced expiratory volume in the first second (FEV1), carbon monoxide diffusion volume (DLCO), FEV1/FVC ratio, planned target area (PTV), mean lung dose (MLD), total number of radiation fields, percentage of lung tissue in total lung volume (vdose), probability of normal tissue complications (NTCP), and other factors.

RESULTS

The proportions of patients aged ≥ 60 years and those with the diagnosis of lung cancer and a history of chemotherapy in the study group were higher than those in the control group ( < 0.05); FEV1, DLCO, and FEV1/FVC ratio in the study group were lower than those in the control group ( < 0.05), while PTV, MLD, total field number, vdose, and NTCP were higher than in the control group ( < 0.05). Logistic regression analysis showed that age, lung cancer diagnosis, chemotherapy history, FEV1, FEV1/FVC ratio, PTV, MLD, total number of radiation fields, vdose, and NTCP were risk factors for radiation pneumonitis.

CONCLUSION

We have identified patient age, type of lung cancer, history of chemotherapy, lung function, and radiotherapy parameters as risk factors for radiation pneumonitis. Comprehensive evaluation and examination should be carried out before radiotherapy to effectively prevent radiation pneumonitis.

摘要

背景

放射性肺炎(RP)是胸部放疗的一种严重并发症,可能导致呼吸困难和肺纤维化,并对患者的生活质量产生负面影响。

目的

对放射性肺炎的影响因素进行多元回归分析。

方法

记录2018年1月至2021年2月在湖州市中心医院(中国浙江省湖州市)接受胸部放疗的234例患者的资料,并根据是否发生放射性肺炎将患者分为研究组和对照组。其中,研究组纳入93例放射性肺炎患者,对照组纳入141例未发生放射性肺炎的患者。收集并比较两组患者的一般特征、放疗及影像学检查数据。由于观察到统计学意义,对年龄、肿瘤类型、化疗史、用力肺活量(FVC)、第1秒用力呼气量(FEV1)、一氧化碳弥散量(DLCO)、FEV1/FVC比值、计划靶区(PTV)、平均肺剂量(MLD)、放疗野总数、肺组织在全肺体积中的百分比(vdose)、正常组织并发症概率(NTCP)等因素进行多元回归分析。

结果

研究组中年龄≥60岁、诊断为肺癌且有化疗史的患者比例高于对照组(P<0.05);研究组的FEV1、DLCO及FEV1/FVC比值低于对照组(P<0.05),而PTV、MLD、野数总数、vdose及NTCP高于对照组(P<0.05)。Logistic回归分析显示,年龄、肺癌诊断、化疗史、FEV1、FEV1/FVC比值、PTV、MLD、放疗野总数、vdose及NTCP是放射性肺炎的危险因素。

结论

我们已确定患者年龄、肺癌类型、化疗史、肺功能和放疗参数是放射性肺炎的危险因素。放疗前应进行综合评估和检查,以有效预防放射性肺炎。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9fbc/9979302/cf69b39ab3bb/WJCC-11-1040-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9fbc/9979302/efe296ffb149/WJCC-11-1040-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9fbc/9979302/e4f22ec88844/WJCC-11-1040-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9fbc/9979302/cf69b39ab3bb/WJCC-11-1040-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9fbc/9979302/efe296ffb149/WJCC-11-1040-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9fbc/9979302/e4f22ec88844/WJCC-11-1040-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9fbc/9979302/cf69b39ab3bb/WJCC-11-1040-g003.jpg

相似文献

1
Multiple regression analysis of risk factors related to radiation pneumonitis.放射性肺炎相关危险因素的多元回归分析
World J Clin Cases. 2023 Feb 16;11(5):1040-1048. doi: 10.12998/wjcc.v11.i5.1040.
2
Acute severe radiation pneumonitis among non-small cell lung cancer (NSCLC) patients with moderate pulmonary dysfunction receiving definitive concurrent chemoradiotherapy: Impact of pre-treatment pulmonary function parameters.中重度肺功能障碍的非小细胞肺癌(NSCLC)患者接受根治性同期放化疗后发生急性重度放射性肺炎:治疗前肺功能参数的影响。
Strahlenther Onkol. 2020 Jun;196(6):505-514. doi: 10.1007/s00066-019-01552-4. Epub 2019 Dec 11.
3
Excluding PTV from lung volume may better predict radiation pneumonitis for intensity modulated radiation therapy in lung cancer patients.对于接受调强放射治疗的肺癌患者,从肺体积中排除 PTV 可能更好地预测放射性肺炎。
Radiat Oncol. 2019 Jan 14;14(1):7. doi: 10.1186/s13014-018-1204-x.
4
Dose-volumetric parameters for predicting severe radiation pneumonitis after three-dimensional conformal radiation therapy for lung cancer.三维适形放疗治疗肺癌后预测严重放射性肺炎的剂量-体积参数
Radiology. 2005 Apr;235(1):208-15. doi: 10.1148/radiol.2351040248. Epub 2005 Feb 9.
5
Poor baseline pulmonary function may not increase the risk of radiation-induced lung toxicity.基础肺功能较差可能不会增加放射性肺毒性的风险。
Int J Radiat Oncol Biol Phys. 2013 Mar 1;85(3):798-804. doi: 10.1016/j.ijrobp.2012.06.040. Epub 2012 Jul 24.
6
Advantages of CyberKnife for inoperable stage I peripheral non-small-cell lung cancer compared to three-dimensional conformal radiotherapy.与三维适形放疗相比,射波刀治疗不可手术的Ⅰ期周围型非小细胞肺癌的优势。
Mol Clin Oncol. 2015 Mar;3(2):442-448. doi: 10.3892/mco.2014.475. Epub 2014 Dec 10.
7
Prediction of radiation pneumonitis: dose-volume histogram analysis in 62 patients with non-small cell lung cancer after three-dimensional conformal radiotherapy.放射性肺炎的预测:62例非小细胞肺癌患者三维适形放疗后剂量体积直方图分析
Neoplasma. 2005;52(1):56-62.
8
Predicting the Risk of Radiation Pneumonitis and Pulmonary Function Changes after Breast Cancer Radiotherapy.预测乳腺癌放疗后放射性肺炎的风险及肺功能变化
J Biomed Phys Eng. 2021 Aug 1;11(4):459-464. doi: 10.31661/jbpe.v0i0.1079. eCollection 2021 Aug.
9
A little to a lot or a lot to a little? An analysis of pneumonitis risk from dose-volume histogram parameters of the lung in patients with lung cancer treated with 3-D conformal radiotherapy.少到多还是多到少?三维适形放疗治疗肺癌患者时,基于肺部剂量体积直方图参数对肺炎风险的分析
Strahlenther Onkol. 2003 Aug;179(8):548-56. doi: 10.1007/s00066-003-1078-0.
10
[Low dose volume histogram analysis of the lungs in prediction of acute radiation pneumonitis in patients with esophageal cancer treated with three-dimensional conformal radiotherapy].[低剂量体积直方图分析在预测食管癌三维适形放疗患者急性放射性肺炎中的应用]
Zhonghua Zhong Liu Za Zhi. 2013 Jan;35(1):45-9. doi: 10.3760/cma.j.issn.0253-3766.2013.01.010.

引用本文的文献

1
Impact of omitting clinical target volume in radiotherapy for locally advanced non-small cell lung cancer: a propensity score matching analysis.局部晚期非小细胞肺癌放疗中省略临床靶体积的影响:一项倾向评分匹配分析
Transl Lung Cancer Res. 2025 May 30;14(5):1770-1785. doi: 10.21037/tlcr-2025-409. Epub 2025 May 28.
2
Concurrent vs. sequential chemoradiotherapy: a survival boost for lung cancer patients.同步放化疗与序贯放化疗:肺癌患者生存率的提高
Biomed Eng Online. 2025 May 16;24(1):60. doi: 10.1186/s12938-025-01390-9.
3
Efficacy and safety of immune checkpoint inhibitors combined with iodine-125 seed implantation in driver gene-negative non-small cell lung cancer: a retrospective cohort study.

本文引用的文献

1
Research Progress on Radiotherapy Combined with Immunotherapy for Associated Pneumonitis During Treatment of Non-Small Cell Lung Cancer.非小细胞肺癌治疗期间放射性肺炎联合免疫治疗的研究进展
Cancer Manag Res. 2022 Aug 13;14:2469-2483. doi: 10.2147/CMAR.S374648. eCollection 2022.
2
Radiation Versus Immune Checkpoint Inhibitor Associated Pneumonitis: Distinct Radiologic Morphologies.放射性肺炎与免疫检查点抑制剂相关性肺炎:不同的影像学形态。
Oncologist. 2021 Oct;26(10):e1822-e1832. doi: 10.1002/onco.13900. Epub 2021 Aug 4.
3
Nosocomial pneumonia diagnosis revisited.
免疫检查点抑制剂联合碘-125粒子植入治疗驱动基因阴性非小细胞肺癌的疗效与安全性:一项回顾性队列研究
J Thorac Dis. 2025 Jan 24;17(1):278-288. doi: 10.21037/jtd-24-1403. Epub 2025 Jan 22.
4
Advances in CT-based lung function imaging for thoracic radiotherapy.基于CT的肺功能成像在胸部放疗中的进展。
Front Oncol. 2024 Sep 2;14:1414337. doi: 10.3389/fonc.2024.1414337. eCollection 2024.
5
Clinical predictors of severe radiation pneumonitis in patients undergoing thoracic radiotherapy for lung cancer.肺癌胸部放疗患者严重放射性肺炎的临床预测因素。
Transl Lung Cancer Res. 2024 May 31;13(5):1069-1083. doi: 10.21037/tlcr-24-328. Epub 2024 May 29.
6
Hydrogen-rich solution alleviates acute radiation pneumonitis by regulating oxidative stress and macrophages polarization.富氢溶液通过调节氧化应激和巨噬细胞极化缓解急性放射性肺炎。
J Radiat Res. 2024 May 23;65(3):291-302. doi: 10.1093/jrr/rrae017.
医院获得性肺炎的诊断方法再评价。
Curr Opin Crit Care. 2020 Oct;26(5):442-449. doi: 10.1097/MCC.0000000000000756.
4
A contemporary review of radiation pneumonitis.辐射性肺炎的当代综述。
Curr Opin Pulm Med. 2020 Jul;26(4):321-325. doi: 10.1097/MCP.0000000000000682.
5
Pretreatment Factors Influencing Radiation Pneumonitis after Stereotactic Body Radiation Therapy in the Treatment of Lung Cancer.立体定向体部放疗治疗肺癌后影响放射性肺炎的预处理因素
Cureus. 2020 Mar 29;12(3):e7462. doi: 10.7759/cureus.7462.
6
Risk stratification of pulmonary toxicities in the combination of whole lung irradiation and high-dose chemotherapy for Ewing sarcoma patients with lung metastases: a review.肺转移尤文肉瘤患者全肺照射联合大剂量化疗肺毒性的危险分层:综述。
Strahlenther Onkol. 2020 Jun;196(6):495-504. doi: 10.1007/s00066-020-01599-8. Epub 2020 Mar 12.
7
Is it possible to achieve more accurate mediastinal nodal radiotherapy planning for NSCLC with PET/CT?利用PET/CT能否为非小细胞肺癌实现更精确的纵隔淋巴结放射治疗计划?
J Pak Med Assoc. 2020 Jan;70(1):29-34. doi: 10.5455/JPMA.296815.
8
Concurrent radiotherapy and chemotherapy with erlotinib followed by maintenance erlotinib in patients with Epidermal Growth Factor Receptor mutation- positive adenocarcinoma lung.表皮生长因子受体突变阳性肺腺癌患者同步进行放疗和厄洛替尼化疗,随后进行厄洛替尼维持治疗。
J Pak Med Assoc. 2019 Nov;69(11):1605-1609. doi: 10.5455/JPMA.297968..
9
Radiation-Induced Lung Injury (RILI).放射性肺损伤(RILI)。
Front Oncol. 2019 Sep 6;9:877. doi: 10.3389/fonc.2019.00877. eCollection 2019.
10
Cellular Stress Responses in Radiotherapy.细胞放射治疗应激反应。
Cells. 2019 Sep 18;8(9):1105. doi: 10.3390/cells8091105.